Key Points
HCLTech will acquire 41,421 equity shares, representing a 10.46% stake in Sarvam AI.
Sarvam AI raised $234 million in the first close of its $300 million Series B round.
HCLTech's all-cash investment totals Rs14.27 billion at a post-money valuation of $1.5 billion for Sarvam.
Sarvam AI reported revenue of Rs451 million in fiscal year 2026, up sharply from Rs15 million.
HCLTech just placed a major bet on India’s sovereign AI ambitions. On June 15, 2026, HCL Technologies (NSE: HCLTECH) announced it would invest $150 million in Sarvam AI as the lead strategic investor in the company’s Series B funding round. HCLTech will acquire 41,421 equity shares, representing a 10.46% stake in Sarvam AI, with the transaction expected to complete within two weeks of signing and requiring no regulatory approval. The investment, confirmed on June 15, 2026, totals INR 1,427.25 crores and marks a significant step toward fostering India’s indigenous AI capabilities. HCLTECH shares traded at ₹1,119.30 on the news, reflecting investor interest in the company’s deepening AI strategy.
Inside the Sarvam AI Deal: Key Numbers
The transaction structure reveals exactly how HCLTech is positioning itself in India’s AI race. Sarvam AI raised $234 million at the first close of its $300 million Series B round, at a post-money valuation of $1.5 billion, with Bessemer Venture Partners joining existing investors Khosla Ventures and Peak XV Partners.
Here are the core deal metrics:
- HCLTech stake acquired: 10.46% (41,421 equity shares)
- Investment amount: $150 million (Rs 14.27 billion / Rs 1,427.25 crores)
- Sarvam AI post-money valuation: $1.5 billion
- Total Series B round size: $300 million; $234 million raised in first close
- Other Series B investors: Bessemer Venture Partners, Khosla Ventures, Peak XV Partners
- Deal structure: All-cash, no regulatory approval required
Sarvam AI, incorporated in July 2023, reported revenue of Rs451 million in fiscal year 2026, compared with just Rs15 million in fiscal year 2025, a dramatic growth trajectory that underscores the company’s rapid commercialisation.
What Sarvam AI Brings to HCLTech’s AI Strategy
Sarvam AI is not a generic AI startup; it is building India’s sovereign AI stack from the ground up. Sarvam builds across the full AI stack: training and inference infrastructure, frontier model research, and a go-to-market motion spanning enterprises, developers, and government, with the investment funding Sarvam’s continued research on training its next frontier model for agentic, coding, and cybersecurity use cases.
The investment will enable HCLTech to develop industry- and client-specific language models and AI solutions for global clients, leveraging and expanding Sarvam’s multilingual AI capabilities in India and globally for sovereign AI applications. This combination of HCLTech’s enterprise reach and Sarvam’s model research creates a differentiated AI platform aimed squarely at enterprise and government clients.
HCLTECH Stock: Where It Stands on June 15, 2026
HCLTECH shares reacted to the Sarvam AI news against a backdrop of broader stock pressure in 2026. The share price of HCLTECH as of June 15, 2026, stood at ₹1,119.30, with a market capitalisation of ₹302,856.47 crore and a 52-week range of ₹1,089.50 to ₹1,780.10.
Key HCLTECH metrics on the day of the announcement:
- Closing price (June 15): ₹1,119.30, up 0.87% from the previous close of ₹1,109.60
- P/E ratio: 18.20
- Dividend yield: 4.84%
- FY26 dividend: Rs 24 per share, marking the 93rd consecutive quarter of dividend payout
- Q4 FY26 total contract value of new deal wins reached $1,936 million, with total headcount at 227,181 as of March 31, 2026
The 12-month average analyst price target for HCLTECH stands at ₹1,427, implying 28.64% upside from current levels, according to a consensus of 40 analysts.
Conclusion
HCLTech’s $150 million Sarvam AI investment is a calculated, strategic move into India’s sovereign AI ecosystem, not a speculative bet. With a 10.46% stake secured, HCLTech gains direct access to frontier AI model research while Sarvam gains enterprise-scale distribution and engineering depth. For HCLTECH shareholders, the deal adds a tangible AI growth lever to a stock currently trading well below its 52-week high and one that analysts see with meaningful upside ahead.
Disclaimer
The content shared by Meyka AI PTY LTD is solely for research and informational purposes. Meyka is not a financial advisory service, and the information provided should not be considered investment or trading advice.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask Meyka Analyst about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)